Phenotype pharmacology of lower urinary tract α 1- adrenoceptors

British Journal of Pharmacology

Volumn 165, Issue 5, 2012, Pages 1226-1234

  Nishimune, A ^a   Yoshiki, H ^a   Uwada, J ^a   Anisuzzaman, A S M ^a   Umada, H ^a   Muramatsu, I ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

1A adrenoceptor; 1L adrenoceptor; benign prostatic hyperplasia (BPH); lower urinary tract; phenotype pharmacology; stress urinary incontinence (SUI)

Indexed keywords

5 CHLORO N [2 (2 CYCLOPROPYLMETHOXYPHENOXY)ETHYL] ALPHA,ALPHA DIMETHYL 1H INDOLE 3 ETHANAMINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CYSTEINE RICH EPIDERMAL GROWTH FACTOR LIKE DOMAIN 1ALPHA; MEMBRANE PROTEIN; PRAZOSIN; SILODOSIN; TAMSULOSIN; UNCLASSIFIED DRUG; YOHIMBINE;

ADRA1A GENE; ADRA1B GENE; ADRA1D GENE; BINDING AFFINITY; BINDING SITE; DRUG ACTIVITY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; GENE FREQUENCY; GENE PRODUCT; GENETIC HETEROGENEITY; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TISSUE DISTRIBUTION; URETHRA; URINARY TRACT;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANIMALS; HUMANS; PHENOTYPE; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1; URINARY TRACT;

EID: 84857090716     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01591.x     Document Type: Review

References (98)

1. Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, et al,. (2006). Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 148: 565-578.
2. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edn. Br J Pharmacol 164 (Suppl. 1): S1-S324.
3. Andersson KE, (1993). Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 45: 253-308.
4. Andersson KE, (2002). Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists. World J Urol 19: 390-396.
5. Andersson KE, Wein AJ, (2004). Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev 56: 581-631.
6. 1L-adrenoceptor mediates contraction of canine subcutaneous resistance arteries. J Pharmacol Exp Ther 295: 627-633.
7. Baker JG, Hill SJ, (2007). Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates. Trends Pharmacol Sci 28: 374-381.
8. 1A/1L-adrenoceptor agonist: a potential therapy of stress urinary incontinence. BJU Int 93: 162-170.
9. 1-adrenergic receptor antagonist. Prostate 39: 226-233.
10. 1A-adrenoceptor antagonist. Eur J Pharmacol 409: 301-312.
11. Chapple CR, (2001). Alpha adrenoceptor antagonists in the year 2000: is there anything new? Curr Opin Urol 11: 9-16.
12. 1-adrenoceptor. Br J Pharmacol 119: 1093-1100.
13. Cooper KL, McKiernan JM, Kaplan SA, (1999). Alpha-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia. Drugs 57: 9-17.
14. Daniels DV, Gever JR, Jasper JR, Kava MS, Lesnick JD, Meloy TD, et al,. (1999). Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies. Eur J Pharmacol 370: 337-343.
15. 1 adrenoceptor subtypes mediate contraction in rabbit prostate and hypogastric artery. Acta Physiol Scand 158: 241-251.
16. Deplanne V, Galzin AM, (1996). Functional characterization of alpha-1-adrenoceptor subtypes in the prostatic urethra and trigone of male rabbit. J Pharmacol Exp Ther 278: 527-534.
17. 1- adrenoceptors? Clin Sci 68 (Suppl. 10): 15s-19s.
18. 1D-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 363: 649-662.
19. 1-adrenoceptor subtypes present in the human prostate. Life Sci 54: 1595-1605.
20. 1-Adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol Sci 7: 347-349.
21. Ford AP, Arredondo NF, Blue DR Jr, Bonhaus DW, Jasper J, Kava MS, et al,. (1996). RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol Pharmacol 49: 209-215.
22. Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD, et al,. (1997). Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 121: 1127-1135.
23. 1C subtype. Mol Pharmacol 45: 703-708.
24. 1-adrenoceptors in the rat prostate. J Urol 172: 2465-2470.
25. Gosling JA, Dixon JS, Jen PYP, (1999). The distribution of noradrenergic nerves in the human lower urinary tract. Eur Urol 38 (Suppl. 1): 23-30.
26. Gray K, Short J, Ventura S, (2008). The alpha1A-adrenoceptor gene is required for the alpha1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate. Br J Pharmacol 155: 103-109.
27. 1-adrenergic receptor subtype expression by bladder outlet obstruction. J Urol 167: 1513-1521.
28. Hieble JP, Bylund DB, Clarke DE, Eikenburg DC, Langer SZ, Lefkowitz RJ, et al,. (1995). International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev 47: 267-270.
29. Hiraizumi-Hiraoka Y, Tanaka T, Yamamoto H, Suzuki F, Muramatsu I, (2004). Identification of alpha-1L adrenoceptor in rabbit ear artery. J Pharmacol Exp Ther 310: 995-1002.
30. 1-adrenoceptor subtypes in the rabbit prostate. J Auton Pharmacol 15: 271-278.
31. 1- adrenoceptor subtypes in the rat prostate. Eur J Pharmacol 366: 119-126.
32. 1C-adrenergic receptor. Biochem Biophys Res Commun 195: 902-909.
33. 1-adrenoceptor expression in rat prostate. Br J Pharmacol 131: 1454-1460.
34. Honda K, Nakagawa C, (1986). Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate. J Pharmacol Exp Ther 239: 512-516.
35. 1- Adrenoceptor subtype mediating contraction of the smooth muscle in the lower urinary tract and prostate of rabbits. Naunyn Schmiedeberg Arch Pharmacol 330: 16-21.
36. 1B-adrenoceptors coexpressed in human embryonic kidney 293 cells. J Pharmacol Exp Ther 309: 259-266.
37. Jensen BC, Swigart PM, Simpson PC, (2009). Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific. Naunyn Schmiedeberg Arch Pharmacol 379: 409-412.
38. 1L-Adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man. Br J Pharmacol 123: 1359-1366.
39. Kenakin T, (1995). On the importance of the 'antagonist assumption' to how receptors express themselves. Biochem Pharmacol 50: 17-26.
40. Kenakin T, (2003). Predicting therapeutic value in the lead optimization phase of drug discovery. Nat Rev Drug Discov 2: 429-438.
41. 1A adrenergic receptor antagonist with high oral bioavailability. J Med Chem 43: 2775-2778.
42. 1- adrenoceptors. Eur Urol 36 (Suppl. 1): 2-6.
43. Larsson B, Sjogren C, Andersson KE, (1986). Regional distribution of alpha-adrenoceptor subtypes in the female rabbit urethra. Acta Physiol Scand 126: 39-43.
44. Lefevre-Borg F, O'Connor SE, Schoemaker H, Lechaire J, Gautier E, et al,. (1993). Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract. Br J Pharmacol 109: 1282-1289.
45. Leonardi A, Hieble JP, Guarneri L, Naselsky DP, Poggesi E, Sironi G, et al,. (1997). Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I. J Pharmacol Exp Ther 281: 1272-1283.
46. Levin RM, Ruggieri MR, Wein AJ, (1988). Identification of receptor subtypes in the rabbit and human urinary bladder by selective radio-ligand binding. J Urol 139: 844-848.
47. Lluel P, Palea S, Ribière P, Barras M, Teillet L, Corman B, (2003). Increased adrenergic contractility and decreased mRNA expression of NOS III in aging rat urinary bladders. Fundam Clin Pharmacol 17: 633-641.
48. Lomasney JW, Cotecchia S, Lefkowitz RJ, Caron MG, (1991). Molecular biology of alpha-adrenergic receptors: implications for receptor classification and for structure-function relationships. Biochim Biophys Acta 1095: 127-139.
49. 1-Adrenergic receptor subtypes in human detrusor. J Urol 160: 937-943.
50. 1c-) adrenoceptor subtype. Br J Pharmacol 115: 781-786.
51. 2- And β-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147: S88-S119.
52. 1-adrenoceptor subtypes and in human prostate. J Auton Pharmacol 16: 21-28.
53. Michelotti GA, Price DT, Schwinn DA, (2000). Alpha-1 adrenergic receptor regulation: basic science and clinical implications. Pharmacol Ther 88: 281-309.
54. Morishima S, Tanaka T, Yamamoto H, Suzuki F, Akino H, Yokoyama O, et al,. (2007). Identification of alpha-1L and alpha-1A adrenoceptors in human prostate by tissue segment binding. J Urol 177: 377-381.
55. Morishima S, Suzuki F, Yoshiki H, Anisuzzaman ASM, Sathi ZS, Tanaka T, et al,. (2008). Identification of alpha-1L adrenoceptor in rat cerebral cortex and possible relationship between alpha-1L and alpha-1A adrenoceptors. Br J Pharmacol 153: 1485-1494.
56. 1L- adrenoceptor in human prostate by the fluorescently labeled ligand alexa-488-silodosin. J Urol 183: 812-819.
57. Muramatsu I, Ohmura T, Kigoshi S, Hashimoto S, Oshita M, (1990). Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle. Br J Pharmacol 99: 197-201.
58. 1-adrenoceptors involved in noradrenaline-induced contractions of rat thoracic aorta and dog carotid artery. Jpn J Pharmacol 57: 535-544.
59. 1-adrenoceptors. Pharmacol Commun 6: 23-28.
60. Muramatsu I, Tanaka T, Suzuki F, Li Z, Hiraizumi-Hiraoka Y, Anisuzzaman AS, et al,. (2005). Quantifying receptor properties: the tissue segment binding method-a powerful tool for the pharmacome analysis of native receptors. J Pharmacol Sci 98: 331-339.
61. Muramatsu I, Morishima S, Suzuki F, Yoshiki H, Anisuzzaman AS, Tanaka T, et al,. (2008). Identification of alpha 1L-adrenoceptor in mice and its abolition by alpha 1A-adrenoceptor gene knockout. Br J Pharmacol 155: 1224-1234.
62. 1-adrenoceptor phenotypes in pigmented and albino rabbit iris. Br J Pharmacol 158: 354-360.
63. Murata S, Taniguchi T, Muramatsu I, (1999). Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand. Br J Pharmacol 127: 19-26.
64. Musselman DM, Ford AP, Gennevois DJ, Harvison ML, Laurent AL, Mokatrin AS, et al,. (2004). A randomized crossover study to evaluate Ro 115-1240, a selective a1A/L-adrenoceptor partial agonist in women with stress urinary incontinence. BJU Int 93: 78-83.
65. 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue. Br J Pharmacol 119: 797-803.
66. 1-adrenoceptor subtype mRNAs in human proximal urethra. Br J Pharmacol 123: 1289-1293.
67. Nelson CP, Challiss RA, (2007). 'Phenotypic' pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem Pharmacol 73: 737-751.
68. 1?-adrenoceptor in the lower urinary tract. Int J Urol 17: 31-37.
69. 1L-adrenoceptor-expressing cell line. J Pharmacol Sci 113: 169-181.
70. 1 and β-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 170: 649-653.
71. 1-adrenoceptors. Eur J Pharmacol 291: 327-334.
72. 1d-adrenoceptors in rabbit. Eur J Pharmacol 396: 9-17.
73. Price DT, Schwinn DA, Lomasney JW, Allen LF, Caron MG, Lefkowitz RJ, (1993). Identification, quantification, and localization of mRNA for three distinct alpha1 adrenergic receptor subtypes in human prostate. J Urol 150: 546-551.
74. Ramsay D, Carr IC, Pediani J, Lopez-Gimenez JF, Thurlow R, Fidock M, et al,. (2004). High-affinity interactions between human alpha1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the alpha1L-adrenoceptor. Mol Pharmacol 66: 228-239.
75. Rang HP, (2006). The receptor concept: pharmacology's big idea. Br J Pharmacol 147: S9-S16.
76. 1C-adrenergic receptor mRNA in adult rat tissues by RNase protection assay and comparison with α1B and α1D. Biochem Biophys Res Commun 200: 1177-1184.
77. Ruffolo R Jr, Hieble JP, (1999). Adrenoceptor Pharmacology: urogenital applications. Eur Urol 36 (Suppl. 1): 17-22.
78. Scofield MA, Liu F, Abel PW, Jeffries WB, (1995). Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J Pharmacol Exp Ther 275: 1035-1042.
79. Stam WB, Van der Graaf PH, Saxena PR, (1999). Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery. Br J Pharmacol 127: 661-670.
80. 1A-adrenoceptor phenotypes in rabbit prostate. Br J Pharmacol 155: 906-912.
81. 1a-adrenoceptor in rabbit. Br J Pharmacol 129: 1569-1576.
82. Takeda M, Hatano A, Arai K, Obara K, Tsutsui T, Takahashi K, (1999). Alpha1- and alpha 2-adrenoceptors in BPH. Eur Urol 36 (Suppl. 1): 31-34.
83. 1-adrenoceptor in the tonus of entire urethra of women. J Urol 162: 1829-2832.
84. Tanaka T, Zhang L, Suzuki F, Muramatsu I, (2004). Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane binding. Br J Pharmacol 141: 468-476.
85. 1a-adrenoceptor expressed in Chinese hamster ovary cells. Br J Pharmacol 127: 962-968.
86. 1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man. Eur J Pharmacol 249: 307-315.
87. Testa R, Guarneri L, Angelico P, Poggesi E, Taddei C, Sironi G, et al,. (1997). Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part II. J Pharmacol Exp Ther 281: 1284-1293.
88. Theroux TL, Esbenshade TA, Minneman KP, (1996). Coupling efficacies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol 50: 1376-1387.
89. 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types. Br J Pharmacol 115: 1475-1485.
90. 1-adrenoceptors in rabbit lower urinary tract and mesenteric artery. Eur J Pharmacol 327: 25-32.
91. Walden PD, Durkin MM, Lepor H, Wetzel JM, Gluchowski C, Gustafson EL, (1997). Localization of mRNA and receptor binding sites for the alpha 1a-adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate. J Urol 157: 1032-1038.
92. Walden PD, Gerardi C, Lepor H, (1999). Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate. J Urol 161: 635-640.
93. Wess J, Eglen RM, Gautam D, (2007). Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 6: 721-733.
94. 1A-adrenoceptor selective antagonists. Br J Pharmacol 127: 252-258.
95. Yablonsky F, Riffaund JP, Lacolle JY, Dausse JP, (1986). Alpha 1- and alpha 2-adrenoceptors in the smooth muscle of male and female rabbit urethra. Eur J Pharmacol 11: 1-8.
96. 1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta. Eur J Pharmacol 315: 73-79.
97. 1A type. Jpn J Pharmacol 62: 297-304.
98. 1A-adrenoceptor mRNA in the rat lower urinary tract. Can J Physiol Pharmacol 82: 872-878.